Breaks Categories: News

WednesdayMar 25, 2026 9:30 am

NetworkNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Engages PRmediaNow and Appoints Strategic Advisor

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced it has engaged PRmediaNow Inc. to provide public relations and media outreach services under a six-month agreement valued at $6,000 per month, along with 150,000 stock options exercisable at $0.25 per share. The company also confirmed it has engaged Investor Brand Network and appointed Tansu Yegen as a strategic advisor, as Planet seeks to expand visibility through earned media coverage across mainstream outlets, trade publications and digital platforms. To view the full press release,…

Continue Reading

WednesdayMar 25, 2026 9:20 am

NetworkNewsBreaks – Frontieras North America Appoints Three Industry Veterans to Board of Directors

Frontieras North America announced the appointment of John Venners, Jean Abiassi and Stephen R. Boatwright to its board of directors, adding expertise in energy policy, infrastructure development and corporate finance as the company advances commercialization of its FASForm(TM) Solid Carbon Fractionation technology in West Virginia. The new directors bring decades of leadership across global energy markets, large-scale construction and capital markets, which the company said will support its transition from engineering milestones to full commercial operations while strengthening execution, financing strategy and long-term growth initiatives. To view the full press release, visit https://nnw.fm/Wnwem About Frontieras North America Frontieras North America…

Continue Reading

WednesdayMar 25, 2026 9:10 am

NetworkNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology

VolitionRx (NYSE American: VNRX) announced proof-of-concept data from a blinded validation cohort demonstrating over 95% sensitivity for stage I and II cancers with 95% specificity using its Capture-Seq liquid biopsy technology. The study, which included 81 subjects, showed detection rates of 94% for stage I and 96% for stage II cancers, with overall sensitivity of 93% and specificity of 95%, highlighting the technology’s potential for early cancer detection. Volition said Capture-Seq is designed to enrich and purify circulating tumor DNA for analysis and may support applications in multi-cancer early detection and minimal residual disease monitoring. The company noted the technology…

Continue Reading

TuesdayMar 24, 2026 11:40 am

NetworkNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Closes $4M Registered Direct Offering Led By Aegis 

ParaZero Technologies (NASDAQ: PRZO) announced the closing of its previously announced registered direct offering with a single institutional investor, generating approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares and pre-funded warrants at $0.75 per share. The transaction, which closed March 24, 2026, will support general corporate purposes and working capital, with Aegis Capital Corp. acting as exclusive placement agent. To view the full press release, visit https://nnw.fm/ZV0x0 About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry. Founded in 2014 by aviation professionals and drone industry veterans, ParaZero is a…

Continue Reading

TuesdayMar 24, 2026 11:18 am

NetworkNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Begins Trading On Frankfurt Stock Exchange

Rail Vision (NASDAQ: RVSN) announced that its ordinary shares have begun trading on the Frankfurt Stock Exchange under the symbol C80, while continuing to trade on the Nasdaq Capital Market under RVSN. The company said the dual listing is expected to enhance visibility and trading liquidity in Europe, broaden its investor base and provide expanded access to European institutional and retail investors. To view the full press release, visit https://nnw.fm/YyyKC About Rail Vision Ltd. Rail Vision is a development stage technology company that is seeking to revolutionize railway safety and the data-related market. The company has developed cutting edge, artificial intelligence based, industry-leading technology specifically…

Continue Reading

TuesdayMar 24, 2026 11:02 am

NetworkNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Launches MyOnlineConsultation Platform Through MOCTeledoc 

Earth Science Tech (OTC: ETST) announced the official launch of MyOnlineConsultation.com through MOCTeledoc LLC, a fully integrated doctor network providing technology and clinical staffing solutions to digital health companies, following a beta phase that achieved cash-flow-positive status. The platform supports ETST’s vertically integrated healthcare ecosystem by connecting its prescriber network with compounding pharmacies, including RxCompound and Mister Meds, while offering turnkey telehealth technology, clinical staffing and integrated fulfillment as the company positions MOCTeledoc as a new revenue stream alongside divisions that generated $25.9 million for the nine months ended Dec. 31, 2025. To view the full press release, visit https://nnw.fm/MM89U About Earth Science Tech, Inc. (ETST) Earth Science…

Continue Reading

TuesdayMar 24, 2026 10:55 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress

NRx Pharmaceuticals (NASDAQ: NRXP) announced the filing of its Form 10-K for the year ended Dec. 31, 2025, highlighting progress across its clinical-stage pipeline and HOPE Therapeutics operations, including advancing two drug candidates toward FDA approval and opening its first HOPE Therapeutics clinics focused on neuroplastic care. The company reported a reduced operating loss of $16.2 million, down from $18.5 million in 2024, alongside lower research and development and general and administrative expenses, and ended the year with approximately $7.8 million in cash, which management believes will support operations through the end of 2026. To view the full press release, visit https://nnw.fm/PZRzL…

Continue Reading

TuesdayMar 24, 2026 10:17 am

NetworkNewsBreaks – American Fusion Inc. (OTC: AMFN) Highlights Participation In Global Energy And Hydrogen Research Events 

American Fusion (OTC: AMFN) is participating in key industry events, including the 17th International Workshop on Anomalies in Hydrogen Loaded Metals (IWAHLM-17), held March 24-26, 2026 in Bergamo, Italy, and the Applied Power Electronics Conference (APEC), taking place March 22-26, 2026 in San Antonio, Texas. The engagements bring together researchers, engineers and industry participants focused on hydrogen-metal systems, power electronics and advanced energy technologies, and are part of the company’s ongoing efforts to remain involved in technical discussions, monitor developments across related fields and build relationships within the broader energy and infrastructure ecosystem. To view the full press release, visit https://nnw.fm/WM9Y6 About American Fusion Inc. American Fusion Inc. (OTC: AMFN) is an…

Continue Reading

TuesdayMar 24, 2026 9:40 am

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Signs MOU With Vulcan Elements To Develop Rare Earth Magnet Supply Chain

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) announced it has executed a memorandum of understanding dated March 16, 2026 with Vulcan Elements Inc. to collaborate on developing a domestic rare earth magnet supply chain for defense and commercial applications, with plans for Ucore to supply NdPr oxide and Dy oxides at commercial scale beginning in 2027. The collaboration links Ucore’s separation platform in Ontario and planned Louisiana Strategic Metals Complex with Vulcan’s North Carolina manufacturing operations, as both companies work toward advancing production, technical specifications and a longer-term commercial supply agreement. To view the full press release, visit https://nnw.fm/a2C7a About…

Continue Reading

TuesdayMar 24, 2026 9:30 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) To Present Deciparticle Platform And Pipeline At BIO-Europe Spring 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present its Deciparticle (TM) nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026 on March 25, where it has been selected as a presenting company. The company will highlight its next-generation drug delivery technology along with two lead candidates, Sapu003 (Everolimus for Injection), currently in Phase 1 trials, and Sapu006 (Docetaxel for Injection), entering Phase 1, as it seeks strategic partnerships to advance development and commercialization. To view the full press release, visit https://nnw.fm/Slq47 About Sapu Nano Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug…

Continue Reading